These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 9001663
1. Catabolic effect in premature infants with early dexamethasone treatment. Tsai FJ, Tsai CH, Wu SF, Liu YH, Yeh TF. Acta Paediatr; 1996 Dec; 85(12):1487-90. PubMed ID: 9001663 [Abstract] [Full Text] [Related]
2. Catabolic effect of dexamethasone in the preterm baby. Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PR. Arch Dis Child; 1992 Jan; 67(1 Spec No):1-4. PubMed ID: 1482427 [Abstract] [Full Text] [Related]
4. Urinary 3-methylhistidine/creatinine ratio as a clinical tool: correlation between 3-methylhistidine excretion and metabolic and clinical states in healthy and stressed premature infants. Seashore JH, Huszar G, Davis EM. Metabolism; 1981 Oct; 30(10):959-69. PubMed ID: 7278650 [Abstract] [Full Text] [Related]
5. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. Cummings JJ, D'Eugenio DB, Gross SJ. N Engl J Med; 1989 Jun 08; 320(23):1505-10. PubMed ID: 2657423 [Abstract] [Full Text] [Related]
6. Urinary 3-methylhistidine excretion and nitrogen balance in healthy and stressed premature infants. Seashore JH, Huszar GB, Davis EM. J Pediatr Surg; 1980 Aug 08; 15(4):400-4. PubMed ID: 6774077 [Abstract] [Full Text] [Related]
7. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. Pediatrics; 1996 Aug 08; 98(2 Pt 1):204-10. PubMed ID: 8692619 [Abstract] [Full Text] [Related]
11. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Kazzi NJ, Brans YW, Poland RL. Pediatrics; 1990 Nov 08; 86(5):722-7. PubMed ID: 2235226 [Abstract] [Full Text] [Related]
12. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia. Ng PC, Brownlee KG, Kelly EJ, Henderson MJ, Smith M, Dear PR. Arch Dis Child; 1992 Oct 08; 67(10 Spec No):1193-5. PubMed ID: 1444557 [Abstract] [Full Text] [Related]
13. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Gross SJ, Anbar RD, Mettelman BB. Pediatrics; 2005 Mar 08; 115(3):681-7. PubMed ID: 15741372 [Abstract] [Full Text] [Related]
14. [Effect of dexamethasone and spironolactone therapy on diuresis and creatine clearance in premature infants with a birth weight below 1,500 g]. Sonntag J. Klin Padiatr; 1996 Mar 08; 208(6):319-22. PubMed ID: 9064372 [Abstract] [Full Text] [Related]
17. A randomized, placebo-controlled GH trial in very preterm infants who were at risk for bronchopulmonary dysplasia and were treated with dexamethasone. Huysman MW, Hop WC, Cromme-Dijkhuis AH, Sauer PJ, Hokken-Koelega AC. Pediatr Res; 2005 Oct 08; 58(4):705-12. PubMed ID: 16189197 [Abstract] [Full Text] [Related]
18. Effect of dexamethasone therapy on the neonatal ductus arteriosus. Morales P, Rastogi A, Bez ML, Akintorin SM, Pyati S, Andes SM, Pildes RS. Pediatr Cardiol; 1998 Oct 08; 19(3):225-9. PubMed ID: 9568218 [Abstract] [Full Text] [Related]